Knight Therapeutics Inc. (TSX:GUD)
5.75
-0.09 (-1.54%)
Jun 27, 2025, 4:00 PM EDT
Knight Therapeutics Employees
Knight Therapeutics had 745 employees as of December 31, 2024. The number of employees increased by 20 or 2.76% compared to the previous year.
Employees
745
Change (1Y)
20
Growth (1Y)
2.76%
Revenue / Employee
500.37K CAD
Profits / Employee
14.85K CAD
Market Cap
572.85M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Sienna Senior Living | 12,263 |
Green Thumb Industries | 4,800 |
dentalcorp Holdings | 10,200 |
Extendicare | 23,000 |
WELL Health Technologies | 1,507 |
Cronos Group | 459 |
Trulieve Cannabis | 6,000 |
Curaleaf Holdings | 5,519 |
Knight Therapeutics News
- 12 days ago - Knight Therapeutics Announces Closing of Previously Announced Acquisition of Paladin - GlobeNewsWire
- 12 days ago - Knight Closes US$50 Million Revolving Credit Facility with NBC - GlobeNewsWire
- 25 days ago - Knight Therapeutics and Sumitomo Pharma enter into Exclusive Licensing Agreements to commercialize Sumitomo's Canadian Portfolio - GlobeNewsWire
- 7 weeks ago - Knight Therapeutics Inc. (KHTRF) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Knight Therapeutics reports Q1 results - Seeking Alpha
- 7 weeks ago - Knight Therapeutics Reports First Quarter 2025 Results - GlobeNewsWire
- 7 weeks ago - Knight Therapeutics Inc. announces voting results from the Annual General Meeting - GlobeNewsWire
- 7 weeks ago - Knight Therapeutics Announces Relaunch of ONICIT® in Brazil and Mexico - GlobeNewsWire